Maltzman Julia D. 4

What Happened

• Julia D. Maltzman, Chief Medical Officer of Adicet Bio (ACET), was granted 72,555 shares as a derivative award on 2026-03-25. The award was recorded at $0.00 per share (no cash paid). This is a grant/award (Form 4 transaction code "A"), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-25; Form 4 filed: 2026-03-27 (within the typical two-business-day reporting window).
• Grant: 72,555 shares; reported price: $0.00 (derivative award, no cash exchanged).
• Shares owned after transaction: Not disclosed in the provided filing summary.
• Footnote: Vesting schedule — 1/48th of the shares vest on each of the next 48 monthly anniversaries of the grant date, subject to continued service (see footnote F1).
• Transaction type code: A = Award/Grant (derivative instrument).

Context

• This appears to be a standard time-based retention award (monthly vesting over four years). Such awards are commonly used to align executive incentives and retain employees; they do not represent an immediate market buy or sale. Because this is a grant (not a purchase), it should be viewed as compensation rather than a direct bullish or bearish insider trade.